Wedbush Lifts Earnings Estimates for ORIC Pharmaceuticals
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for ORIC Pharmaceuticals in a research report issued to clients and investors on Monday, May 5th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.48) for the quarter, up from […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for ORIC Pharmaceuticals in a research report issued to clients and investors on Monday, May 5th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.48) for the quarter, up from […]
